ELI LILLY & Co·4

Feb 3, 4:32 PM ET

Yuffa Ilya 4

4 · ELI LILLY & Co · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly EVP Ilya Yuffa Converts RSUs; Withholds 1,512 Shares

What Happened

  • Ilya Yuffa, EVP & President, LLY USA & Global Capabilities at Eli Lilly (LLY), had 3,394 restricted stock units (RSUs) convert to common shares on Feb 1, 2026 (reported on Form 4 filed Feb 3, 2026).
  • Of the 3,394 shares that vested/converted, 1,512.364 shares were withheld to cover taxes (transaction code F) at an effective price of $1,037.15 per share, totaling $1,568,548. The RSU conversion (transaction code M) is recorded at $0 (no cash exercise price).
  • Net shares retained by Yuffa after withholding: 3,394 − 1,512.364 = 1,881.636 shares (calculation based on the filing).

Key Details

  • Transaction date: 2026-02-01. Form filed: 2026-02-03 (within the normal 2-business-day Form 4 reporting window).
  • Actions recorded: M (exercise/conversion) — 3,394 RSUs converted to shares; F (tax withholding) — 1,512.364 shares disposed/withheld to satisfy tax withholding.
  • Withheld shares price and value: $1,037.15 per share; total withholding value $1,568,548.
  • Footnote: F1 — each restricted stock unit represents a contingent right to receive one share of Eli Lilly common stock.
  • Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

  • This was not an open-market buy or sell for cash. It was an RSU vesting/conversion with shares withheld to cover taxes (a common, routine "net settlement" of equity awards).
  • For retail investors: such tax-withholding dispositions are routine and do not necessarily indicate the insider's view on the company's stock. They are different from voluntary sales or purchases.

Insider Transaction Report

Form 4
Period: 2026-02-01
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-01+3,39429,653.971 total
  • Tax Payment

    Common Stock

    2026-02-01$1037.15/sh1,512.364$1,568,54828,141.607 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1]
    2026-02-013,3940 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (3,394 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for Ilya Yuffa, pursuant to authorization on file|2026-02-03

Documents

1 file
  • 4
    wk-form4_1770154355.xmlPrimary

    FORM 4